Article Versions Notes

Blateau P, Coyaud E, Laurent E, Béganton B, Ducros V, Chauchard G, Vendrell JA, Solassol J. TERT Promoter Mutation as an Independent Prognostic Marker for Poor Prognosis MAPK Inhibitors-Treated Melanoma. Cancers. 2020; 12(8):2224. https://doi.org/10.3390/cancers12082224

Blateau, Pauline, Etienne Coyaud, Estelle Laurent, Benoit Béganton, Vincent Ducros, Géraldine Chauchard, Julie A. Vendrell, and Jérôme Solassol. 2020. "TERT Promoter Mutation as an Independent Prognostic Marker for Poor Prognosis MAPK Inhibitors-Treated Melanoma" Cancers 12, no. 8: 2224. https://doi.org/10.3390/cancers12082224

Blateau, P., Coyaud, E., Laurent, E., Béganton, B., Ducros, V., Chauchard, G., Vendrell, J. A., & Solassol, J. (2020). TERT Promoter Mutation as an Independent Prognostic Marker for Poor Prognosis MAPK Inhibitors-Treated Melanoma. Cancers, 12(8), 2224. https://doi.org/10.3390/cancers12082224